These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38863913)

  • 21. Severe hypoglycemia secondary to methimazole-induced insulin autoimmune syndrome in a 16 year old African-American male.
    Gomez Cruz MJ; Jabbar M; Saini N; Eng D; Crawford B; Vazquez DM; Menon R; Chen M
    Pediatr Diabetes; 2012 Dec; 13(8):652-5. PubMed ID: 22759245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patients with Graves' disease who developed insulin autoimmune syndrome (Hirata disease) possess HLA-Bw62/Cw4/DR4 carrying DRB1*0406.
    Uchigata Y; Kuwata S; Tsushima T; Tokunaga K; Miyamoto M; Tsuchikawa K; Hirata Y; Juji T; Omori Y
    J Clin Endocrinol Metab; 1993 Jul; 77(1):249-54. PubMed ID: 8325948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppression of Graves' hyperthyroidism--still an elusive goal.
    Wiersinga WM
    N Engl J Med; 1996 Jan; 334(4):265-6. PubMed ID: 8532007
    [No Abstract]   [Full Text] [Related]  

  • 24. Carbimazole induced ANCA positive vasculitis.
    Pandey S; Kushwaha RS; Mehndiratta P; Mehndiratta MM
    J Assoc Physicians India; 2008 Oct; 56():801-3. PubMed ID: 19263707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin autoimmune syndrome: a case associated with HLA-DRB1 polymorphism.
    Zhang Q; Chen SG; Sheng CJ; Cheng XY; Li H; Sheng H; Yang P; Qian CH; Li WJ; Qu S
    J Endocrinol Invest; 2011; 34(7):568-9. PubMed ID: 21897108
    [No Abstract]   [Full Text] [Related]  

  • 26. Case report: autoimmune insulin syndrome in a Chinese female with Graves' disease.
    Wong ST; Ng WY; Thai AC
    Ann Acad Med Singap; 1996 Nov; 25(6):882-5. PubMed ID: 9055022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Graves' orbitopathy precipitated by iatrogenic hypothyroidism secondary to carbimazole for Graves' disease.
    Dutta D; Kumar M; Mukhopadhyay S; Chowdhury S
    Indian J Pediatr; 2014 Nov; 81(11):1244-5. PubMed ID: 24777624
    [No Abstract]   [Full Text] [Related]  

  • 28. Prognostic value of thyrotrophin binding inhibiting immunoglobulins (TBII) in longterm antithyroid treatment, 131I therapy given in combination with carbimazole and in euthyroid ophthalmopathy.
    Bliddal H; Kirkegaard C; Siersbaek-Nielsen K; Friis T
    Acta Endocrinol (Copenh); 1981 Nov; 98(3):364-9. PubMed ID: 6170200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy.
    Sabri O; Zimny M; Schreckenberger M; Reinartz P; Ostwald E; Buell U
    Thyroid; 1999 Dec; 9(12):1181-8. PubMed ID: 10646656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgG-class insulin autoantibodies in autoimmune thyroid disease.
    Ng WY; Thai AC; Lui KF; Yeo PP; Cheah JS
    Int Arch Allergy Appl Immunol; 1990; 91(4):431-6. PubMed ID: 2210877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoglycemia due to insulin binding antibodies in a patient with insulin-treated type 2 diabetes and Graves' disease.
    Wang X; Xu XL; Zhao XL; Ma XW; Yu H; Gong H; Zhang SR; Chen FL
    Endocrine; 2013 Feb; 43(1):236-7. PubMed ID: 22886314
    [No Abstract]   [Full Text] [Related]  

  • 32. Graves disease associated with chronic idiopathic urticaria: 2 case reports.
    Bansal AS; Hayman GR
    J Investig Allergol Clin Immunol; 2009; 19(1):54-6. PubMed ID: 19274930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experience with carbimazole in the treatment of the hyperthyroidism of Graves' disease in Nigerian patients.
    Modebe O
    Afr J Med Med Sci; 1995 Dec; 24(4):347-51. PubMed ID: 8886149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The adjunctive use of carbimazole during radioactive iodine treatment reduces the cure rate of Graves' disease.
    Docrat F; Mokoena T; Karusseit VOL; Ankrah AO
    S Afr Med J; 2021 Feb; 111(2):176-179. PubMed ID: 33944730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbimazole treatment in smokers vs nonsmokers with Graves disease.
    Shin JI; Lee JS
    JAMA; 2009 May; 301(19):1988-9; author reply 1989. PubMed ID: 19454634
    [No Abstract]   [Full Text] [Related]  

  • 36. A randomized trial of short-term treatment of Graves' disease with high-dose carbimazole plus thyroxine versus low-dose carbimazole.
    Grebe SK; Feek CM; Ford HC; Fagerström JN; Cordwell DP; Delahunt JW; Toomath RJ
    Clin Endocrinol (Oxf); 1998 May; 48(5):585-92. PubMed ID: 9666870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leucocytoclastic vasculitis associated with antithyroid therapy in Graves' disease.
    Miller RM; Savige J; Nassis L; Cominos BI
    Australas J Dermatol; 1998 May; 39(2):96-9. PubMed ID: 9611379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential evolution of thyroid peroxidase and thyrotropin receptor antibodies in Graves' disease: thyroid peroxidase antibody activity reverts to pretreatment level after carbimazole withdrawal.
    Guilhem I; Massart C; Poirier JY; Maugendre D
    Thyroid; 2006 Oct; 16(10):1041-5. PubMed ID: 17042691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunosuppressive effects of antithyroid drugs.
    Ratanachaiyavong S; McGregor AM
    Clin Endocrinol Metab; 1985 May; 14(2):449-66. PubMed ID: 2415278
    [No Abstract]   [Full Text] [Related]  

  • 40. Carbimazole-induced myositis in the treatment of Graves' disease: a complication in genetically susceptible individuals?
    Lim AY; Kek PC; Soh AW
    Singapore Med J; 2013 Jul; 54(7):e133-6. PubMed ID: 23900475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.